These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26089636)

  • 1. Visual field changes as an early indicator of glioblastoma multiforme progression: two cases of functional vision changes before MRI detection.
    Xie K; Liu CY; Hasso AN; Crow RW
    Clin Ophthalmol; 2015; 9():1041-7. PubMed ID: 26089636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral malignant optic glioma following glioblastoma multiforme in the young: a case report and literature review.
    Lin CY; Huang HM
    BMC Ophthalmol; 2017 Mar; 17(1):21. PubMed ID: 28284199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Malignant progression of an anaplastic ganglioglioma into a glioblastoma multiforme--report on two cases and review of the literature].
    Naydenov E; Tzekov C; Minkin K; Nachev S; Marinov M
    Khirurgiia (Sofiia); 2009; (2-3):69-74. PubMed ID: 20506796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multicentric Glioblastoma Multiforme Mimicking Optic Neuritis.
    Pellegrini F; Lee AG; Cercato C
    Neuroophthalmology; 2018 Apr; 42(2):112-116. PubMed ID: 29563957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Rapid Progression in Early-Stage Primary Glioblastoma Multiforme:A Case Report].
    Maehara N; Amano T; Haga S; Makihara K; Shimogawa T; Hatae R; Yoshimoto K; Suzuki S; Morioka T; Iihara K
    No Shinkei Geka; 2016 Nov; 44(11):945-950. PubMed ID: 27832617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home palliative care and end of life issues in glioblastoma multiforme: results and comments from a homogeneous cohort of patients.
    Pompili A; Telera S; Villani V; Pace A
    Neurosurg Focus; 2014 Dec; 37(6):E5. PubMed ID: 25434390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre-irradiation tumour volumes defined by MRI and dual time-point FET-PET for the prediction of glioblastoma multiforme recurrence: A prospective study.
    Harat M; Małkowski B; Makarewicz R
    Radiother Oncol; 2016 Aug; 120(2):241-7. PubMed ID: 27378734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of subventricular zone involvement in relation to tumor volumes defined by fused MRI and O-(2-[
    Harat M; Małkowski B; Roszkowski K
    Radiat Oncol; 2019 Mar; 14(1):37. PubMed ID: 30832691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Added Prognostic Value of Metabolic Tumor Size on FDG-PET at First Suspected Recurrence of Glioblastoma Multiforme.
    Chiang GC; Galla N; Ferraro R; Kovanlikaya I
    J Neuroimaging; 2017 Mar; 27(2):243-247. PubMed ID: 27515717
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.
    Liu ZC; Yan LF; Hu YC; Sun YZ; Tian Q; Nan HY; Yu Y; Sun Q; Wang W; Cui GB
    BMC Med Imaging; 2017 Feb; 17(1):10. PubMed ID: 28143434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term survival and complete response of a patient with recurrent diffuse intrinsic brain stem glioblastoma multiforme.
    Burzynski SR; Lewy RI; Weaver R; Janicki T; Jurida G; Khan M; Larisma CB; Paszkowiak J; Szymkowski B
    Integr Cancer Ther; 2004 Sep; 3(3):257-61. PubMed ID: 15312271
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Aiming for zero blindness].
    Nakazawa T
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):168-93; discussion 194. PubMed ID: 25854109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging.
    Yamamoto Y; Wong TZ; Turkington TG; Hawk TC; Reardon DA; Coleman RE
    Mol Imaging Biol; 2006; 8(6):340-7. PubMed ID: 17051323
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of early [18F]fluoroethyltyrosine positron emission tomography after radiochemotherapy in glioblastoma multiforme.
    Piroth MD; Pinkawa M; Holy R; Klotz J; Nussen S; Stoffels G; Coenen HH; Kaiser HJ; Langen KJ; Eble MJ
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):176-84. PubMed ID: 20646863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Early Postoperative O-(2-
    Buchmann N; Gempt J; Ryang YM; Pyka T; Kirschke JS; Meyer B; Ringel F
    World Neurosurg; 2019 Jan; 121():e467-e474. PubMed ID: 30267942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Computational Trials: Unraveling Motility Phenotypes, Progression Patterns, and Treatment Options for Glioblastoma Multiforme.
    Raman F; Scribner E; Saut O; Wenger C; Colin T; Fathallah-Shaykh HM
    PLoS One; 2016; 11(1):e0146617. PubMed ID: 26756205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between magnetic resonance imaging features and miRNA gene expression in patients with glioblastoma multiforme.
    Li WB; Chen HY; Zhang W; Yan W; Shi R; Li SW; Jiang T
    Chin Med J (Engl); 2013; 126(15):2881-5. PubMed ID: 23924460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
    Sultanem K; Patrocinio H; Lambert C; Corns R; Leblanc R; Parker W; Shenouda G; Souhami L
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):247-52. PubMed ID: 14697445
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of adjuvant or salvage radiosurgery in the management of unresected residual or progressive glioblastoma multiforme in the pre-bevacizumab era.
    Niranjan A; Kano H; Iyer A; Kondziolka D; Flickinger JC; Lunsford LD
    J Neurosurg; 2015 Apr; 122(4):757-65. PubMed ID: 25594327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. (18)F-Fluoroethyl-l-Thyrosine Positron Emission Tomography to Delineate Tumor Residuals After Glioblastoma Resection: A Comparison with Standard Postoperative Magnetic Resonance Imaging.
    Buchmann N; Kläsner B; Gempt J; Bauer JS; Pyka T; Delbridge C; Meyer B; Krause BJ; Ringel F
    World Neurosurg; 2016 May; 89():420-6. PubMed ID: 26893043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.